Blackbaud Earnings Calls
| Release date | Oct 29, 2025 |
| EPS estimate | $1.07 |
| EPS actual | $1.10 |
| EPS Surprise | 2.80% |
| Revenue estimate | 292.535M |
| Revenue actual | 281.143M |
| Revenue Surprise | -3.89% |
| Release date | Jul 30, 2025 |
| EPS estimate | - |
| EPS actual | $0.538 |
| Revenue estimate | - |
| Revenue actual | 281.382M |
| Release date | Apr 30, 2025 |
| EPS estimate | $0.90 |
| EPS actual | $0.96 |
| EPS Surprise | 6.67% |
| Revenue estimate | 276.082M |
| Revenue actual | 270.661M |
| Revenue Surprise | -1.96% |
| Release date | Feb 18, 2025 |
| EPS estimate | $1.08 |
| EPS actual | $1.08 |
| Revenue estimate | 276.804M |
| Revenue actual | 302.232M |
| Revenue Surprise | 9.19% |
Last 4 Quarters for Blackbaud
Below you can see how BLKB performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Feb 18, 2025 |
| Price on release | $70.96 |
| EPS estimate | $1.08 |
| EPS actual | $1.08 |
| Date | Price |
|---|---|
| Feb 11, 2025 | $79.60 |
| Feb 12, 2025 | $79.08 |
| Feb 13, 2025 | $80.79 |
| Feb 14, 2025 | $79.88 |
| Feb 18, 2025 | $70.96 |
| Feb 19, 2025 | $68.52 |
| Feb 20, 2025 | $66.22 |
| Feb 21, 2025 | $68.24 |
| Feb 24, 2025 | $68.90 |
| 4 days before | -10.85% |
| 4 days after | -2.90% |
| On release day | -3.44% |
| Change in period | -13.44% |
| Release date | Apr 30, 2025 |
| Price on release | $60.54 |
| EPS estimate | $0.90 |
| EPS actual | $0.96 |
| EPS surprise | 6.67% |
| Date | Price |
|---|---|
| Apr 24, 2025 | $63.43 |
| Apr 25, 2025 | $63.77 |
| Apr 28, 2025 | $63.85 |
| Apr 29, 2025 | $64.06 |
| Apr 30, 2025 | $60.54 |
| May 01, 2025 | $61.09 |
| May 02, 2025 | $61.40 |
| May 05, 2025 | $62.54 |
| May 06, 2025 | $62.21 |
| 4 days before | -4.56% |
| 4 days after | 2.76% |
| On release day | 0.91% |
| Change in period | -1.92% |
| Release date | Jul 30, 2025 |
| Price on release | $71.61 |
| EPS estimate | - |
| EPS actual | $0.538 |
| Date | Price |
|---|---|
| Jul 24, 2025 | $65.25 |
| Jul 25, 2025 | $65.40 |
| Jul 28, 2025 | $64.06 |
| Jul 29, 2025 | $64.50 |
| Jul 30, 2025 | $71.61 |
| Jul 31, 2025 | $67.42 |
| Aug 01, 2025 | $65.28 |
| Aug 04, 2025 | $64.78 |
| Aug 05, 2025 | $63.12 |
| 4 days before | 9.75% |
| 4 days after | -11.86% |
| On release day | -5.85% |
| Change in period | -3.26% |
| Release date | Oct 29, 2025 |
| Price on release | $67.95 |
| EPS estimate | $1.07 |
| EPS actual | $1.10 |
| EPS surprise | 2.80% |
| Date | Price |
|---|---|
| Oct 23, 2025 | $64.71 |
| Oct 24, 2025 | $65.18 |
| Oct 27, 2025 | $64.46 |
| Oct 28, 2025 | $64.15 |
| Oct 29, 2025 | $67.95 |
| Oct 30, 2025 | $65.92 |
| Oct 31, 2025 | $64.04 |
| Nov 03, 2025 | $63.88 |
| Nov 04, 2025 | $62.06 |
| 4 days before | 5.01% |
| 4 days after | -8.67% |
| On release day | -2.99% |
| Change in period | -4.10% |
Blackbaud Earnings Call Transcript Summary of Q3 2025
Blackbaud reported a strong Q3 2025: revenue of $281M (organic growth 5.2%), adjusted EBITDA margin of 35.4% (up ~220 bps YoY), non-GAAP EPS of $1.10 (up 11% YoY) and very strong adjusted free cash flow of $125M (up 28% YoY). Management reiterated full-year 2025 guidance (revenue $1.120B–$1.130B; non-GAAP EPS $4.30–$4.50) while raising adjusted free cash flow guidance to $195M–$205M due primarily to expected cash tax savings from recent tax legislation. The company is investing incrementally (~$7M in Q3–Q4) in AI and agentic AI (“Agents for Good”), beginning monetization this quarter with expected modest revenue in 2026 and a larger ramp thereafter. Operational levers highlighted include margin expansion via infrastructure optimization, productivity gains from AI, continued transactional revenue strength across three payment platforms, and growing average ARR from larger, multiyear deals (minimum contract term now generally 3 years, with many 4+ years). Capital allocation priorities remain buybacks (increasing 2025 repurchase target to 5.2%–7%), continued share reduction (nearly 2M shares repurchased through Q3, ~10% reduction since Q4 2023), debt paydown optionality, and selective tuck-in M&A. Financial health notes: leverage improved to ~2.4x, one-time working capital headwinds (~$60M) expected in 2025 not to repeat in 2026, and an immaterial prior-period tax accounting correction disclosed.
Sign In
Buy BLKB